| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 02/12/2004 | WO2003024976A3 Tricyclic indole derivatives as 5-ht ligands |
| 02/12/2004 | WO2002058698A3 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 02/12/2004 | US20040030380 Drug-delivery endovascular stent and method for treating restenosis |
| 02/12/2004 | US20040030137 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands |
| 02/12/2004 | US20040030130 Methods of asymmetrically synthesizing enantiomers of casodex, its derivatives and intermediates thereof |
| 02/12/2004 | US20040029933 Substituted phenylacetic acids |
| 02/12/2004 | US20040029908 Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
| 02/12/2004 | US20040029882 Antimicrobial quinolones, their compositions and uses |
| 02/12/2004 | US20040029879 Viricides for herpes virus |
| 02/12/2004 | US20040029868 Multiple sclerosis; atherosclerosis; inflamamtory bowel diseases; asthma |
| 02/12/2004 | US20040029867 Anticoagulants; cardiovascular disorders |
| 02/12/2004 | DE10232780A1 Co-Tenside auf Basis von Aldehyden Co-surfactants based on aldehydes |
| 02/12/2004 | CA2494421A1 Condensed pyridines and pyrimidines with tie2 (tek) activity |
| 02/11/2004 | EP1388541A1 Pyrrolopyrazines as kinase inhibitors |
| 02/11/2004 | EP1387850A2 Antiviral nucleosides |
| 02/11/2004 | EP1387842A1 Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors |
| 02/11/2004 | CN1474821A New cephalotaxanes, their method of preapartion and their use in treatment of cancers, leukemias, parasites including thus resistant to usual chemotherapentic agents and reversal agents |
| 02/11/2004 | CN1474652A Substituted 4,5-dihydro-1,2,4-triazin -6-ones, 1,2,4-triazin-6-ones, and their use as fungicides and insecticides |
| 02/11/2004 | CN1473827A 3-position substituted quinolone derivativers and its use in pharmacy |
| 02/11/2004 | CN1137680C Aerosol compositions |
| 02/10/2004 | US6689890 Efficient lactam synthesis |
| 02/10/2004 | US6689769 Bactericides |
| 02/10/2004 | US6689724 Antioxidants and antioxidant boosters capable of producing hydroperoxyl radicals |
| 02/05/2004 | WO2004011457A1 1-phenylpiperidin-3-one derivatives and processes for the preparation thereof |
| 02/05/2004 | WO2002100886A8 Pyrrolidin-2-one derivatives as inhibitors of factor xa |
| 02/05/2004 | US20040024725 Regulated apoptosis |
| 02/05/2004 | US20040024450 Drug-delivery endovascular stent and method for treating restenosis |
| 02/05/2004 | US20040024190 Viral polymerase inhibitors |
| 02/05/2004 | US20040024038 GABA enhancers in the treatment of diseases relating to reduced neurosteroid activity |
| 02/05/2004 | US20040023956 New intermediates and synthetic methods for the stereospecific synthesis of oxazinone compounds, which are useful, for example, as antibiotics. The invention also pertains to novel olefinic oxazinone compounds, methods for |
| 02/05/2004 | US20040023893 Coumarin derivatives for treatment of vascular disorders, skin disorders or allergies |
| 02/05/2004 | US20040023290 Novel therapeutic agents that modulate enzymatic processes |
| 02/05/2004 | DE10231368A1 Verfahren zur Herstellung von Imidazoliumsalzen Process for the preparation of imidazolium salts |
| 02/04/2004 | EP1386912A1 Cyclic amidine derivative |
| 02/04/2004 | EP1385852A1 Compounds and methods for inhibiting mrp1 |
| 02/04/2004 | EP1385851A1 New process for the preparation of oxabispidines |
| 02/04/2004 | EP1385850A1 New process for the preparation of oxabispidines |
| 02/04/2004 | EP1385845A1 N-aroyl cyclic amines |
| 02/04/2004 | CN1473161A Pyrazole compounds as protein kinase inhibitors |
| 02/04/2004 | CN1137100C Tricyclic compounds capable of inhibiting tyrosine kinases of epidermal growth factor receptor family |
| 02/03/2004 | US6686468 For use in synthetic resins to obtain violet to blue tints; used in phototropic glasses |
| 02/03/2004 | US6686349 Administering to a patient for the treatment of sexual dysfunction an effective amount of substituted tetracyclic pyrroloquinolone derivatives |
| 02/03/2004 | US6686318 Heterocyclically substituted aromatic amino compounds with a herbicidal effect |
| 01/29/2004 | WO2004009603A1 Dihydro-dibenzo[b,e]oxepine based selective estrogen receptor modulators, compositions and methods |
| 01/29/2004 | WO2004009578A2 Pentacyclic oxepines and derivatives thereof, process for their preparation and pharmaceutical compositions containing them |
| 01/29/2004 | WO2004009564A2 Co-surfactants based on aldehydes |
| 01/29/2004 | WO2004009079A1 Chondropsin-class antitumor v-atpase inhibitor compounds, compositions and methods of use thereof |
| 01/29/2004 | WO2003032905A3 Preparation and use of carbohydrate-based ring structures with antimicrobial and cytostatic activity |
| 01/29/2004 | US20040019218 Reacting nitrogen compounds such as benzoxazole, with grignard reagents to form chemical intermediates used to form cysteine protease inhibitors |
| 01/29/2004 | US20040019214 Carbocyclic carbo, oxo amines such as N-heptyl-3-methyl-4-oxo -1,4-dihydroquinoline-2-carboxamide, used for prophylaxis of gastrointerstinal disorders |
| 01/29/2004 | US20040019061 1-H-3-arylpirrolidine-2,4-dione derivatives |
| 01/29/2004 | US20040019059 Drugs such as N-(4-benzoylphenyl)-4,5-dihydro-3-(3-pyridinyl)-5-isoxazolecarboxamide, used as antiinflammatory or antiarthritic agents |
| 01/29/2004 | US20040019051 Eating disorders of a disturbed or impaired fundus such as dyspepsia, early satiety, bloating and anorexia; e.g.,1-(1-((2,3-dihydro(1,4)dioxino(2,3-b)pyridin-3-yl)methyl) -4- piperidinyl)-2-imidazolidinone |
| 01/29/2004 | US20040019037 E.g.,((5-(2,4-Diaminopyrimidin-6-yl)pentanoyl)-(N-methyl)amino )-3-(6-meth-oxypyridin-3-yl)-propanoic acid, inhibition of bone resorption, restenosis, angiogenesis inhibitors, antiarthritic, -tumor, -carcinogenic agents; antidiabetic |
| 01/29/2004 | US20040019019 Administering a bicyclic or tricyclic amidino derivative compounds for the treatment of diseases mediated by nitric oxide synthase |
| 01/29/2004 | CA2492912A1 Co-surfactants based on aldehydes |
| 01/28/2004 | EP1383771A1 9-deazaguanine derivatives as inhibitors of gsk-3 |
| 01/28/2004 | EP1383749A1 Arylsulfonamides as antiviral agents |
| 01/28/2004 | EP1383748A2 Novel compounds and compositions as cathepsin inhibitors |
| 01/28/2004 | EP1383743A2 Dual inhibitors of pde 7 and pde 4 |
| 01/28/2004 | EP1383741A2 Process for the preparation of benazepril |
| 01/28/2004 | EP1383733A2 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds |
| 01/28/2004 | EP1383506A2 Fused heterocyclic inhibitors of phosphodiesterase (pde) 7 |
| 01/28/2004 | EP1299378A4 Tetrahydropyridino or piperidino heterocyclic derivatives |
| 01/28/2004 | CN1136203C Benzoxazine and penzothiazine derivatives and their use in pharmaceuticals |
| 01/27/2004 | US6683110 4-(4-ethoxyphenyl)-2-(n'-fluoren-9-ylidenehydrazino)-2-hydroxy -4-oxobutyric acid methyl ester; 2-(4-bromophenyl-amino)-5,5-dimethyl-4-oxohex-2-enoic acid methyl ester |
| 01/27/2004 | US6682782 Organic compound having an acetylene group, vacuum deposition polymerization thereof, deposited polymerized thin film, and electroluminescence device containing same |
| 01/22/2004 | WO2004007709A2 Production of polyketides |
| 01/22/2004 | WO2004007501A1 Biologically active compounds |
| 01/22/2004 | WO2004007465A1 Method for producing imidazolium salts |
| 01/22/2004 | WO2004006846A2 Receptor-type kinase modulators and methods of use |
| 01/22/2004 | WO2003080545A3 Substituted phenylacetic acids |
| 01/22/2004 | WO2003064383A3 Phosphorus-containing compounds & uses thereof |
| 01/22/2004 | WO2003055447A3 Heterocyclic acridone inhibitors of impdh enzyme |
| 01/22/2004 | US20040014753 Antiinflammatory agents; enzyme inihibitor; autoimmune diseases; antiarthritic agents; central nervous system disorders |
| 01/22/2004 | US20040014750 Therapy, prevention atherosclerosis; cardiovascular disorders; anticholesterol agents; bactericides; prevention infections |
| 01/22/2004 | US20040014749 Sulfhydryl rifamycins and uses thereof |
| 01/22/2004 | US20040014747 CRF receptor antagonists and methods relating thereto |
| 01/22/2004 | US20040014743 Mbreast and prostate anticancer agents; viricides; alopecia |
| 01/22/2004 | US20040014392 Heat resistance |
| 01/22/2004 | US20040014168 Solid support comprises bead having diameter of 400-600 mu m functionalized with a silicon-containing linker |
| 01/22/2004 | CA2621093A1 Production of polyketides and other natural products |
| 01/22/2004 | CA2499465A1 Biologically active compounds |
| 01/22/2004 | CA2491191A1 Receptor-type kinase modulators and methods of use |
| 01/21/2004 | EP1381613A1 Antidepressant azaheterocyclylmethyl derivatives of oxaheterocycle-fused- 1,4]-benzodioxans |
| 01/21/2004 | EP1381592A1 1,4-disubstituted benzo-fused compounds |
| 01/21/2004 | CN1469875A Pyrazole compounds useful as protein kinase inhibitors |
| 01/21/2004 | CN1469874A Pyrazole compounds useful as protein kinase inhibitors |
| 01/21/2004 | CN1469873A Piperidine compounds as anti-allergic |
| 01/15/2004 | WO2004005472A2 Inhibitors of ftsz and uses thereof |
| 01/15/2004 | WO2004005298A1 Derivatives of rifabutine useful as antimicrobial agents |
| 01/15/2004 | US20040010005 Stereoselective process for preparing cylcohexyl amine derivatives |
| 01/15/2004 | US20040010002 Also identifying agents that are useful for alleviating and inhibiting lymphoproliferative disorders or inhibiting metastasis of lymphatic tumors |
| 01/15/2004 | US20040009984 Increasing levels of endogenous growth hormone, especially treating osterporosis, aging frailty or congestive heart failure |
| 01/15/2004 | US20040009977 For use in the prophylaxis and the treatment of Picornavirus and human rotavirus infections. |
| 01/14/2004 | EP1380587A2 Oxazolo, thiazolo and selenazolo (4,5-c)-quinoline-4-amines and analogs thereof |
| 01/14/2004 | EP1380575A1 1,2-disubstituted 1,4-dihydro-4-oxoquinoline compounds |
| 01/14/2004 | EP1379531A2 Enzymatic process for preparing cephalosporanic acid derivatives using alpha-ketoacid derivatives |
| 01/14/2004 | EP1379527A1 Epindolidione pigments |
| 01/14/2004 | EP1379247A1 Agent for topical ophthalmic treatment of ocular inflammatory diseases |